Sprycel recognized as essential medicine

BMS Korea says its Sprycel (dasatinib), an oral inhibitor of multiple tyrosine kinases, has been recommended for use as one of essential medicines from the national deliberation committees consisting of oncologists.

Dasatinib is approved for the treatment of adults with chronic, accelerated or blast phase chronic myeloid leukaemia (CML) with resistance or intolerance to prior therapy includi...